Several autonomous communities asked Health that the option that those under 60 years of age who so wish could be vaccinated with AstraZeneca. However, this Wednesday the sixth update of the vaccination strategy against Covid-19 reject this possibility.
According to the Public Health commission, it is not “timely” Offer the Vaxzevria vaccine (formerly AstraZeneca) to people under the age of 60 who voluntarily want to get vaccinated. «The proposal can not only enter into contradiction with ethical principles on which the Strategy itself is based, but also, if still not enough information is available to make the most appropriate decision, the value of informed consent as a guarantee of an autonomous decision, would be highly debatable since it would hardly have been possible to offer them adequate information in the terms required by law before receiving the vaccine, ”they indicate in the update.
Likewise, they explain that “it must be taken into account that the vaccine to be administered cannot be at the request or choice of the individuals” and insist that “the choice of the vaccine or vaccines to be applied cannot be established by individual choices, but must be based on the efficacy and indication of the vaccine (s) for the different population groups ”.
The first doses of Janssen
The update also confirms that the first doses of Janssen’s vaccine will be used in the 70-79 year group, although they may also be administered to group 4, that of people considered as highly dependent (degree III dependency, that is, in need of intense support measures) who are not currently institutionalized.
In addition, the new strategy establishes that people who belong to the active groups with an essential function for society (group 6) they will get the vaccine available after vaccinating people over 60 years old instead of being vaccinated with AstraZeneca as before.
Protection against infection
The report indicates that of the total number of institutionalized people (408,881), 98% have received at least one dose and 91% have already received the full regimen. This has led to a notable decrease in nursing homes for the elderly. risk of contracting Covid-19. Specific, decreased 57.2% 14 days after the first dose, amounting to 81,2% after the second dose.
There is also a indirect protection in unvaccinated people living in residences with a high vaccination rate. “These results confirm the effectiveness of mRNA vaccination in the institutionalized elderly population and, furthermore, support the universal vaccination policy in this setting, even in people with previous infection,” they indicate.